(Q64947984)

English

Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

scientific article published on 10 April 2019

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

1

object named as

Young Eun Chon

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

6

object named as

Beom Kyung Kim

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

Seong Gyu Hwang

11

object named as

Seong Gyu Hwang

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

13

object named as

Kyu Sung Rim

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

author name string

Hana Park

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

Hye Kyung Hyun

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

Yeonjung Ha

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

Mi Na Kim

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

Joo Ho Lee

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

Do Young Kim

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

publication date

10 April 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

copyright license

Creative Commons Attribution 4.0 International

10 April 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Serum C-reactive protein level and the impact of cytoreductive surgery in patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammation and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The immunobiology of cancer immunosurveillance and immunoediting

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunology of hepatitis B virus and hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer-related inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of hepatocellular carcinoma: An update

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response rate and clinical outcome of HCC after first and repeated cTACE performed "on demand"

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of serum C-reactive protein level on the prognosis of patients with hepatocellular carcinoma undergoing TACE.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic inflammation and cytokines in the tumor microenvironment

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retreatment with TACE: the ABCR SCORE, an aid to the decision-making process.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophils in the Tumor Microenvironment

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AASLD guidelines for the treatment of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment options after sorafenib failure in patients with hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of liver cancer in South Korea

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database

1 reference

https://pubmed.ncbi.nlm.nih.gov/30974843

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3390/CANCERS11040509

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30974843%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64947984&oldid=1886664720"